When Patients Can't Afford Their Growth Hormone, They Stop Taking It

Growth hormone deficiency (GHD) is a chronic condition that requires long-term treatment. Saizen (Somatropin) is one of the most effective therapies available — but it's also one of the most expensive. When patients face monthly costs of $800 to $3,000+ out of pocket, adherence drops. Prescriptions go unfilled. Treatment gaps widen. Outcomes suffer.

As a provider, you can't control drug pricing. But you can help patients navigate the savings landscape — and often the difference between a patient staying on therapy and abandoning it comes down to whether someone in your practice takes 10 minutes to explore their options.

This guide covers every major savings pathway for Saizen, so you and your staff can have informed cost conversations and connect patients with real financial relief.

What Patients Are Actually Paying

Understanding the cost landscape is the first step to helping patients find savings.

Cash Prices

• Saizen 5 mg vial: $737–$900 per vial
• Saizen 8.8 mg vial: $1,150–$1,500 per vial
• Monthly cost range: $800–$3,000+ depending on dose and formulation

With Insurance

Most commercial plans and some Medicare plans cover growth hormone therapy, but the patient experience varies dramatically:

• Prior authorization is required by virtually all payers. Stimulation test results, diagnosis codes, and clinical documentation must be submitted.
• Step therapy is common — many plans require trial of a preferred brand (often Norditropin or Omnitrope) before approving Saizen.
• Specialty pharmacy requirement — most plans mandate dispensing through a designated specialty pharmacy.
• Specialty tier copays — even with coverage, patients may face 20–40% coinsurance on specialty tier medications, which on a $1,200 vial translates to $240–$480 per fill.

Without Insurance

Uninsured patients face the full cash price. For a patient requiring the 8.8 mg vial weekly, that's potentially $4,600–$6,000+ per month — obviously unsustainable for the vast majority of patients.

Manufacturer Savings Programs

EMD Serono, the manufacturer of Saizen, offers several support programs that your staff should know about.

Co-Pay Assistance Program

For commercially insured patients, EMD Serono's co-pay assistance program can significantly reduce out-of-pocket costs. Details:

• Available to patients with commercial insurance (not Medicare, Medicaid, or other government programs)
• Reduces copay or coinsurance amounts
• Patients can enroll through EMD Serono's patient support website (emdserono.com) or by calling the patient support line

Clinical pearl: Have your specialty pharmacy coordinator keep EMD Serono's support number readily available. Many patients don't know these programs exist until someone tells them.

Patient Assistance Program (PAP)

For uninsured or underinsured patients, EMD Serono offers a Patient Assistance Program that provides free medication to qualifying patients. Eligibility is typically based on income and insurance status.

Additionally, Prescription Hope offers Saizen for $70/month through their patient assistance service, which can be a game-changer for patients who don't qualify for manufacturer PAPs or who find the application process burdensome.

How to Refer Patients

Your office can help patients access these programs by:

1. Providing the EMD Serono patient support contact information
2. Helping patients gather required documentation (proof of income, insurance status, prescription)
3. Having a staff member follow up to ensure the application was submitted
4. Directing patients to Prescription Hope as an alternative pathway

Coupon and Discount Cards

For patients paying cash or facing high copays, discount programs can offer meaningful savings.

GoodRx

GoodRx coupons can bring the cash price of Saizen down to approximately $287 at participating pharmacies — a significant reduction from the $700+ retail price. However:

• GoodRx coupons cannot be combined with insurance
• Prices vary by pharmacy and may not reflect specialty pharmacy pricing
• Best suited for patients who are paying entirely out of pocket

Other Discount Programs

Several other discount card programs may offer savings on Somatropin products:

• SingleCare
• RxSaver
• Optum Perks
• BuzzRx

Provider tip: Direct patients to compare prices across multiple discount platforms, as pricing can vary significantly. Resources like Medfinder for Providers can help streamline this process.

Generic Alternatives and Therapeutic Substitution

While there is no true generic version of Saizen, there are cost-effective alternatives worth discussing with patients.

Omnitrope (Biosimilar)

Omnitrope (Sandoz) was the first biosimilar growth hormone approved in the United States (2006). It contains the same Somatropin molecule and is FDA-approved for the same indications.

• Cost: Typically $500–$900 per month depending on dose — potentially significant savings versus Saizen
• Insurance: Many plans prefer Omnitrope due to lower cost, which can also mean lower copays for patients
• Clinical equivalence: Same molecule, same mechanism of action, same efficacy profile

Other Brand Alternatives

If cost or availability is an issue with Saizen, consider these alternatives:

• Norditropin FlexPro (Novo Nordisk) — Pre-filled pen, widely preferred by payers. No reconstitution required, which improves adherence.
• Genotropin (Pfizer) — GoQuick pens and Miniquick single-use devices. Good for patients who prefer convenience.
• Humatrope (Eli Lilly) — Available in vials and pen cartridges. Broad indication coverage.

Each manufacturer has its own savings programs, so switching brands may also open up new copay assistance options. See our clinical guide on alternatives to Saizen for a detailed comparison.

Therapeutic Substitution Considerations

All Somatropin brands contain the same molecule, making therapeutic substitution straightforward from a clinical standpoint. When considering a switch:

• Verify the new brand's dose equivalency (all are dosed in mg of Somatropin)
• Ensure the patient is trained on any new delivery device
• Update prior authorization with the new brand
• Check that the patient's specialty pharmacy carries the replacement brand

Building Cost Conversations Into Your Workflow

The most effective way to prevent cost-related non-adherence is to make financial discussions a routine part of care.

At Diagnosis

When first prescribing growth hormone therapy:

• Discuss expected costs upfront — patients should know what they're likely to pay before they go to the pharmacy
• Check insurance formulary to identify the preferred brand (this avoids prior auth denials and step therapy delays)
• Connect the patient with your specialty pharmacy coordinator immediately
• Provide information about manufacturer savings programs at the first visit

At Each Follow-Up

Build a brief cost check into your follow-up template:

• "Are you having any trouble affording your medication?"
• "Have there been any changes to your insurance?"
• "Are you using any copay assistance programs?"

Patients often won't volunteer financial concerns unless asked directly.

When Prior Authorization Is Denied

Denial is common with growth hormone therapy. Your workflow should include:

1. Appeal promptly — Most denials can be overturned with additional documentation (stimulation test results, clinical notes demonstrating medical necessity)
2. Peer-to-peer review — Request a physician-to-physician review with the insurance medical director
3. Consider brand switching — If the denial is brand-specific, switching to the plan's preferred brand may resolve the issue faster than an appeal
4. Bridge supply — While appealing, help the patient access medication through manufacturer samples or patient assistance programs to avoid treatment gaps

Staff Training

Ensure your clinical and administrative staff understand:

• The basics of growth hormone pricing and insurance requirements
• How to direct patients to manufacturer savings programs
• The prior authorization process and common denial reasons
• When and how to initiate appeals

Consider designating one staff member as your "growth hormone navigator" who becomes the expert on these workflows.

Additional Resources

• NeedyMeds (needymeds.org) — Database of patient assistance programs and discount opportunities
• RxAssist (rxassist.org) — Comprehensive directory of pharmaceutical assistance programs
• Medfinder for Providers — Helps your patients find pharmacies with Saizen in stock and compare pricing
• EMD Serono Patient Support (emdserono.com) — Manufacturer programs and resources

Final Thoughts

Growth hormone therapy changes lives — but only when patients can actually afford and access it. The cost of Saizen is a real barrier, and providers who proactively address it see better adherence, fewer treatment gaps, and improved outcomes.

You don't need to become a billing expert. You just need to know the major savings pathways exist, make financial conversations routine, and ensure someone on your team is equipped to guide patients through the process.

For more clinical resources on Saizen, see our provider guides on managing Saizen shortage challenges and helping patients find Saizen in stock.